139 related articles for article (PubMed ID: 3609110)
1. Duration of action of tiapamil in stable exercise induced angina.
Maltz MB; Davies DW; Caplin JL; Camm AJ
Eur J Clin Pharmacol; 1987; 32(4):339-42. PubMed ID: 3609110
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris.
O'Keefe JC; Maltz MB; Butrous GS; Camm AJ
Eur Heart J; 1986 Oct; 7(10):843-7. PubMed ID: 3539614
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris.
Khurmi NS; Raftery EB
Cardiovasc Drugs Ther; 1987; 1(1):81-7. PubMed ID: 3154312
[TBL] [Abstract][Full Text] [Related]
4. Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris.
Khurmi NS; Robinson CW; O'Hara MJ; Raftery EB
Eur J Clin Pharmacol; 1986; 30(4):387-92. PubMed ID: 3743614
[TBL] [Abstract][Full Text] [Related]
5. Acute antianginal effect of tiapamil.
Gasic S
Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
[TBL] [Abstract][Full Text] [Related]
6. Long-term tiapamil treatment of patients with angina pectoris.
Salorinne Y; Himberg JJ; Eskelinen E
Clin Cardiol; 1983 Apr; 6(4):171-5. PubMed ID: 6404577
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: a multicenter trial.
Sykulski R; Keller N; Storm T; Stokke O; Myhre T; Himanen P; Quitzau K
Cardiovasc Drugs Ther; 1989 Jun; 3(3):427-31. PubMed ID: 2487539
[TBL] [Abstract][Full Text] [Related]
8. Effects of tiapamil, a new calcium channel blocker, on ambulatory intraarterial blood pressure and exercise-induced changes in blood pressure.
Caruana M; Al-Khawaja I; Prince H; Raftery EB
J Cardiovasc Pharmacol; 1986; 8(5):1074-7. PubMed ID: 2429082
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
[TBL] [Abstract][Full Text] [Related]
10. Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.
Balansard P; Elkik F; Levenson JA; Ciampi M; Sans P
Br J Clin Pharmacol; 1984 Dec; 18(6):823-9. PubMed ID: 6529523
[TBL] [Abstract][Full Text] [Related]
11. Tiapamil dose ranging study on exercise performance in patients with exercise induced angina and coronary artery disease.
Maltz MB; O'Keefe JC; Butrous GS; Camm AJ
Arq Bras Cardiol; 1984 Jun; 42(6):443-6. PubMed ID: 6393922
[No Abstract] [Full Text] [Related]
12. Acute effects of felodipine in exertional angina pectoris.
Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
Am J Cardiol; 1988 Apr; 61(10):691-5. PubMed ID: 3354431
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of molsidomine on exercise tolerance in patients with exertional angina pectoris.
Kinoshita M; Sawamura M; Motomura M; Takayama Y; Kawaguchi Y; Kawakita S
Jpn Circ J; 1983 Dec; 47(12):1398-405. PubMed ID: 6689183
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculography.
Eckert M; Pozenel H; Pillat B
J Clin Pharmacol; 1984 Apr; 24(4):165-73. PubMed ID: 6725618
[TBL] [Abstract][Full Text] [Related]
15. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic effect of intravenous tiapamil on methylergometrine-induced coronary artery spasm in patients with variant angina: randomized double-blind trial.
Danchin N; Clozel JP; Khalife K; Elkik F; Boulay F; Neimann JL; Cherrier F
Am Heart J; 1985 Apr; 109(4):764-8. PubMed ID: 3885699
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of tiapamil in patients with mild to moderate essential hypertension.
Lacourcière Y; Carrier M; Toal CB
J Cardiovasc Pharmacol; 1989 Jul; 14(1):166-70. PubMed ID: 2475708
[TBL] [Abstract][Full Text] [Related]
19. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
[TBL] [Abstract][Full Text] [Related]
20. Serial M-mode echocardiography in evaluation of the cardiovascular effects of tiapamil and their relationship to plasma levels in patients with coronary heart disease.
Lindvall K; Cocco G; Wendt G; Chu D; Heizmann P
Int J Cardiol; 1981; 1(1):15-24. PubMed ID: 7333712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
